HighGravityData
Companies / Equinix / Filing

Equinix — Feb 11, 2026 release

Fiscal 2025 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001101239-26-000030
Open on SEC.gov ↗
Showing in the filing
Revenues
“$2.496 and $2.536 billion”
Period
Q1 FY2026
Measure
GAAP-tied
Source
Prose
All guidance in this release · 24
Quarterly cash dividend
“$5.16 per share”
Revenues for FY2026
“$10,123 - 10,223”
Adjusted EBITDA Margin % for Q1 FY2026
“51 - 52%”
Recurring Capital Expenditures % of Revenues for FY2026
“~3%”
Recurring Capital Expenditures % of Revenues for Q1 FY2026
“1 - 2%”
AFFO per Share (Diluted) for FY2026
“$41.93 - 42.74”
Expected Cash Dividends for FY2026
“~$2,036”
Revenues for Q1 FY2026
“$2.496 and $2.536 billion”
Adjusted EBITDA for Q1 FY2026
“$1.283 and $1.323 billion”
Recurring capital expenditures for Q1 FY2026
“$28 and $48 million”
Total revenues for FY2026
“$10.123 and $10.223 billion”
Total revenues growth (as-reported) for FY2026
“approximately 10 - 11%”
Total revenues growth (normalized and consta… for FY2026
“9 - 10%”
Adjusted EBITDA for FY2026
“$5.141 and $5.221 billion”
Adjusted EBITDA margin for FY2026
“51%”
Adjusted EBITDA margin expansion for FY2026
“approximate 200 basis-point expansion”
AFFO for FY2026
“$4.158 and $4.238 billion”
AFFO growth (as-reported) for FY2026
“11 - 13%”
AFFO growth (normalized and constant currency) for FY2026
“9 - 11%”
AFFO per share growth (as-reported) for FY2026
“9 - 12%”
AFFO per share growth (normalized and consta… for FY2026
“8 - 10%”
Total capital expenditures for FY2026
“$3.655 and $4.155 billion”
Non-recurring capital expenditures (excludes… for FY2026
“$3.385 and $3.865 billion”
Recurring capital expenditures for FY2026
“$270 and $290 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Equinix intends to calculate the various non-GAAP financial measures in future periods consistent with how they were calculated for the periods presented within this press release. For the first quarter of 2026, the company expects revenues to range between $2.496 and $2.536 billion, an increase of 4% at the midpoint over the previous quarter, on both an as-reported and a normalized and constant currency basis. This guidance includes a $20 million foreign currency benefit when compared to the average FX rates in Q4 2025. Adjusted EBITDA is expected to range between $1.283 and $1.323 billion. This guidance includes an $11 million foreign currency benefit when compared to the average FX rates in Q4 2025. Recurring capital expenditures are expected to range between $28 and $48 million. For the full year of 2026, total revenues are expected to range between $10.123 and $10.223 billion, an as-reported increase of approximately 10 - 11% over the previous year, or 9 - 10% on a normalized and constant currency basis. This guidance includes a $36 million foreign currency benefit when compared to the prior guidance rates. Adjusted EBITDA is expected to range between $5.141 and $5.221 billion, reflecting an adjusted EBITDA margin of 51%, an approximate 200 basis-point expansion over the previous year. This guidance also includes a $17 million foreign currency benefit when compared to prior guidance. AFFO is expected to range between $4.158 and $4.238 billion, an increas
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.